|
|
|
Sunday, March 25, 2007 - 8:30 AM, Elizabeth H
|
- Differentiating the Undifferentiated and Poorly Differentiated Sarcomas: a Multidisciplinary Approach
|
|
Moderator:
|
Josep Lloreta-Trull, Hospital del Mar, Pompeu Fabra University, Barcelona, Spain
|
|
|
Disclosure:
|
The speakers have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to download handout in 1-per-page format for the entire meeting
Click here to download handout in 6-per-page format for the entire meeting
Click any blue title below to display and print the handout for individual lecture(s):
| 8:30 | Undifferentiated Sarcomas: What to Do? And, Does it Matter? - Christopher D.M. Fletcher, Brigham & Women's Hospital, Boston, MA |
| 9:00 | Recognizing Hidden Phenotypes in Sarcomas through the Electron Microscope - Marco Santucci, University of Florence Medical School, Univ. Hospital Careggi, Firenze, Italy |
| 9:30 | Sarcoma Look - alikes: An Ultrastructural Approach - Guillermo A. Herrera, St. Louis University School of Medicine, St. Louis, MO |
| 10:00 | Break |
| 10:30 | Contribution of Cytogenetics to the Management of Poorly Differentiated Sarcomas - Julia A. Bridge, Nebraska Health System, Omaha, NE |
| 11:00 | Molecular Profiling in the Diagnosis and Treatment of High Grade Sarcomas - Cristina Antonescu, Memorial Sloan-Kettering Cancer Center, New York, NY |
| Society officers decided to present a program conveying up-to-date practical information while at the same time introducing elements of translational research which have the greatest impact on daily practice. Sarcomas can be challenging and both their prognosis and treatment quite often rely on pathological assessment. The purpose of this symposia will be to review the current role of light and electron microscopy, as ell as that of cytogenetics and molecular profiling in the study of undifferentiated and poorly differentiated sarcomas. A panel of outstanding experts will put into perspective the relevant contributions, which could have an impact in the management of patients with such tumors. |
|
|
|
